Other Species / Isoforms
  MLP (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T14-p
KAPRGDVtAEEAAGA
0 16
MLP (human) KAPRGDVtAEEAAGA T14-p
MLP (mouse) KAPRGDVtAEEAAGA T14-p
MLP (rat) KAPRGDVTAEEAAGA T14
S22-p
AEEAAGAsPAkANGQ
Upstream
0 89
Treatment
  • anti-CD3
  • nocodazole
MLP (human) AEEAAGAsPAkANGQ S22-p
MLP (mouse) AEEAAGAsPAkANGQ S22-p
MLP (rat) AEEAAGAsPAKANGQ S22-p
K25-ub
AAGAsPAkANGQENG
0 8
MLP (human) AAGAsPAkANGQENG K25-ub
MLP (mouse) AAGAsPAkANGQENG K25-ub
MLP (rat) AAGAsPAKANGQENG K25
K35-ub
GQENGHVksNGDLsP
0 1
MLP (human) GQENGHVksNGDLsP K35-ub
MLP (mouse) GQENGHVRsNGDLtP R35
MLP (rat) GQENGHVKSNGDLtP K35
S36-p
QENGHVksNGDLsPk
0 26
MLP (human) QENGHVksNGDLsPk S36-p
MLP (mouse) QENGHVRsNGDLtPK S36-p
MLP (rat) QENGHVKSNGDLtPK S36
S41-p
VksNGDLsPkGEGEs
0 18
MLP (human) VksNGDLsPkGEGEs S41-p
MLP (mouse) VRsNGDLtPKGEGEs T41-p
MLP (rat) VKSNGDLtPKGEGES T41-p
K43-ub
sNGDLsPkGEGEsPP
0 1
MLP (human) sNGDLsPkGEGEsPP K43-ub
MLP (mouse) sNGDLtPKGEGEsPP K43
MLP (rat) SNGDLtPKGEGESPP K43
S48-p
sPkGEGEsPPVNGtD
0 13
MLP (human) sPkGEGEsPPVNGtD S48-p
MLP (mouse) tPKGEGEsPPVnGTD S48-p
MLP (rat) tPKGEGESPPVNGAD S48
N52
EGEsPPVNGtDEAAG
0 1
MLP (human) EGEsPPVNGtDEAAG N52
MLP (mouse) EGEsPPVnGTDEAAG N52-ng
MLP (rat) EGESPPVNGADEAAG N52
T54-p
EsPPVNGtDEAAGAt
0 2
MLP (human) EsPPVNGtDEAAGAt T54-p
MLP (mouse) EsPPVnGTDEAAGAT T54
MLP (rat) ESPPVNGADEAAGAT A54
T61-p
tDEAAGAtGdAIEPA
0 3
MLP (human) tDEAAGAtGdAIEPA T61-p
MLP (mouse) TDEAAGATGDAIEPA T61
MLP (rat) ADEAAGATGDAIEPA T61
D63-ca
EAAGAtGdAIEPAPP
0 1
MLP (human) EAAGAtGdAIEPAPP D63-ca
MLP (mouse) EAAGATGDAIEPAPP D63
MLP (rat) EAAGATGDAIEPAPP D63
S71-p
AIEPAPPsQGAEAKG
Upstream
0 47
Putative in vivo kinases:
  • ATR (human)
Treatment
  • UV
MLP (human) AIEPAPPsQGAEAKG S71-p
MLP (mouse) AIEPAPPsQEAEAKG S71-p
MLP (rat) AIEPAPPSQEAEAKG S71
K83-ub
AKGEVPPkEtPKkKK
0 1
MLP (human) AKGEVPPkEtPKkKK K83-ub
MLP (mouse) AKGEVAPKEtPKKKK K83
MLP (rat) AKGEVAPKEtPKKKK K83
T85-p
GEVPPkEtPKkKKKF
Upstream
0 94
Treatment
  • LRRK2-IN-1
  • nocodazole
MLP (human) GEVPPkEtPKkKKKF T85-p
MLP (mouse) GEVAPKEtPKKKKKF T85-p
MLP (rat) GEVAPKEtPKKKKkF T85-p
K88-ub
PPkEtPKkKKKFsFk
0 1
MLP (human) PPkEtPKkKKKFsFk K88-ub
MLP (mouse) APKEtPKKKKKFsFK K88
MLP (rat) APKEtPKKKKkFSFk K88
K91
EtPKkKKKFsFkKPF
0 1
MLP (human) EtPKkKKKFsFkKPF K91
MLP (mouse) EtPKKKKKFsFKKPF K91
MLP (rat) EtPKKKKkFSFkKPF K91-ac
S93-p
PKkKKKFsFkKPFkL
Upstream
1 92
Treatment
  • angiotensin_2
  • ischemia
  • nocodazole
MLP (human) PKkKKKFsFkKPFkL S93-p
MLP (mouse) PKKKKKFsFKKPFKL S93-p
MLP (rat) PKKKKkFSFkKPFkL S93
K95
kKKKFsFKKPFkLsG
0 1
MLP (human) kKKKFsFKKPFkLsG K95
MLP (mouse) KKKKFsFKKPFKLsG K95
MLP (rat) KKKkFSFkKPFkLsG K95-ac
K95-ub
kKKKFsFkKPFkLsG
0 1
MLP (human) kKKKFsFkKPFkLsG K95-ub
MLP (mouse) KKKKFsFKKPFKLsG K95
MLP (rat) KKKkFSFKKPFkLsG K95
K99
FsFkKPFKLsGLsFk
0 1
MLP (human) FsFkKPFKLsGLsFk K99
MLP (mouse) FsFKKPFKLsGLsFk K99
MLP (rat) FSFkKPFkLsGLsFk K99-ac
K99-ub
FsFkKPFkLsGLsFk
0 2
MLP (human) FsFkKPFkLsGLsFk K99-ub
MLP (mouse) FsFKKPFKLsGLsFk K99
MLP (rat) FSFkKPFKLsGLsFk K99
S101-p
FkKPFkLsGLsFkRN
Upstream
0 59
Treatment
  • angiotensin_2
  • BI_4834
  • EGF
  • LRRK2-IN-1
  • nocodazole
MLP (human) FkKPFkLsGLsFkRN S101-p
MLP (mouse) FKKPFKLsGLsFkRN S101-p
MLP (rat) FkKPFkLsGLsFkRN S101-p
S104-p
PFkLsGLsFkRNRkE
Upstream
1 132
Treatment
  • angiotensin-(1-7)
  • angiotensin_2
  • anti-CD3
  • EGF
  • ischemia
  • LRRK2-IN-1
  • MEK_inhibitor_I
  • metastatic potential
  • nocodazole
MLP (human) PFkLsGLsFkRNRkE S104-p
MLP (mouse) PFKLsGLsFkRNRkE S104-p
MLP (rat) PFkLsGLsFkRNRKE S104-p
K106-ac
kLsGLsFkRNRkEGG
0 46
MLP (human) kLsGLsFkRNRkEGG K106-ac
MLP (mouse) KLsGLsFkRNRkEGG K106-ac
MLP (rat) kLsGLsFkRNRKEGG K106-ac
K106-ub
kLsGLsFkRNRkEGG
0 5
MLP (human) kLsGLsFkRNRkEGG K106-ub
MLP (mouse) KLsGLsFKRNRkEGG K106
MLP (rat) kLsGLsFKRNRKEGG K106
K110-ub
LsFkRNRkEGGGDss
0 6
MLP (human) LsFkRNRkEGGGDss K110-ub
MLP (mouse) LsFkRNRkEGGGDss K110-ub
MLP (rat) LsFkRNRKEGGGDSS K110
S116-p
RkEGGGDssAssPtE
0 6
MLP (human) RkEGGGDssAssPtE S116-p
MLP (mouse) RkEGGGDssAssPtE S116-p
MLP (rat) RKEGGGDSSASSPTE S116
S117-p
kEGGGDssAssPtEE
0 3
MLP (human) kEGGGDssAssPtEE S117-p
MLP (mouse) kEGGGDssAssPtEE S117-p
MLP (rat) KEGGGDSSASSPTEE S117
S119-p
GGGDssAssPtEEEQ
0 7
MLP (human) GGGDssAssPtEEEQ S119-p
MLP (mouse) GGGDssAssPtEEEQ S119-p
MLP (rat) GGGDSSASSPTEEEQ S119
S120-p
GGDssAssPtEEEQE
Upstream
1 12
Treatment
  • ischemia
MLP (human) GGDssAssPtEEEQE S120-p
MLP (mouse) GGDssAssPtEEEQE S120-p
MLP (rat) GGDSSASSPTEEEQE S120
T122-p
DssAssPtEEEQEQG
0 6
MLP (human) DssAssPtEEEQEQG T122-p
MLP (mouse) DssAssPtEEEQEQG T122-p
MLP (rat) DSSASSPTEEEQEQG T122
G132
EQEQGEIGACsDEGT
0 4
MLP (human) EQEQGEIGACsDEGT G132
MLP (mouse) EQEQGEMsACsDEGT S132-p
MLP (rat) EQEQGEISACsDEGT S132
S135-p
QGEIGACsDEGTAQE
0 13
MLP (human) QGEIGACsDEGTAQE S135-p
MLP (mouse) QGEMsACsDEGTAQE S135-p
MLP (rat) QGEISACsDEGTAQE S135-p
K144-ub
EGTAQEGkAAAtPEs
0 1
MLP (human) EGTAQEGkAAAtPEs K144-ub
MLP (mouse) EGTAQEGKAAAtPEs K144
MLP (rat) EGTAQEGKAAAtPES K144
T148-p
QEGkAAAtPEsQEPQ
Upstream
1 94
Treatment
  • quinalizarin
MLP (human) QEGkAAAtPEsQEPQ T148-p
MLP (mouse) QEGKAAAtPEsQEPQ T148-p
MLP (rat) QEGKAAAtPESQEPQ T148-p
S151-p
kAAAtPEsQEPQAKG
0 55
MLP (human) kAAAtPEsQEPQAKG S151-p
MLP (mouse) KAAAtPEsQEPQAkG S151-p
MLP (rat) KAAAtPESQEPQAKG S151
K157
EsQEPQAKGAEAsAA
0 6
MLP (human) EsQEPQAKGAEAsAA K157
MLP (mouse) EsQEPQAkGAEAsAA K157-ub
MLP (rat) ESQEPQAKGAEASAV K157
S162-p
QAKGAEAsAAsEEEA
0 6
MLP (human) QAKGAEAsAAsEEEA S162-p
MLP (mouse) QAkGAEAsAAsKEGD S162-p
MLP (rat) QAKGAEASAVSKGGD S162
S165-p
GAEAsAAsEEEAGPQ
0 13
MLP (human) GAEAsAAsEEEAGPQ S165-p
MLP (mouse) GAEAsAAsKEGDtEE S165-p
MLP (rat) GAEASAVSKGGDAEE S165
-
gap
0 6
MLP (human) gap -
MLP (mouse) AAsKEGDtEEEAGPQ T170-p
MLP (rat) AVSKGGDAEEEAGPQ A170
T174-p
EEAGPQAtEPstPsG
0 4
MLP (human) EEAGPQAtEPstPsG T174-p
MLP (mouse) EEAGPQAAEPstPsG A179
MLP (rat) EEAGPQAAEPSTPSG A179
S177-p
GPQAtEPstPsGPEs
0 10
MLP (human) GPQAtEPstPsGPEs S177-p
MLP (mouse) GPQAAEPstPsGPEs S182-p
MLP (rat) GPQAAEPSTPSGPEs S182
T178-p
PQAtEPstPsGPEsG
1 71
MLP (human) PQAtEPstPsGPEsG T178-p
MLP (mouse) PQAAEPstPsGPEsG T183-p
MLP (rat) PQAAEPSTPSGPEsG T183
S180-p
AtEPstPsGPEsGPT
0 10
MLP (human) AtEPstPsGPEsGPT S180-p
MLP (mouse) AAEPstPsGPEsGPt S185-p
MLP (rat) AAEPSTPSGPEsGPA S185
S184-p
stPsGPEsGPTPAsA
0 6
MLP (human) stPsGPEsGPTPAsA S184-p
MLP (mouse) stPsGPEsGPtPASA S189-p
MLP (rat) STPSGPEsGPASASA S189-p
T187
sGPEsGPTPAsAEQN
0 3
MLP (human) sGPEsGPTPAsAEQN T187
MLP (mouse) sGPEsGPtPASAEQN T192-p
MLP (rat) SGPEsGPASASAENE A192
S190-p
EsGPTPAsAEQNE__
0 1
MLP (human) EsGPTPAsAEQNE__ S190-p
MLP (mouse) EsGPtPASAEQNE__ S195
MLP (rat) EsGPASASAENE___ S195